Editas Medicine EDIT
NASDAQ EDIT
$3.15 +0.08 (+2.44%)
As of: Sep 4, 2026 · 3:13 PM EDT

Editas Medicine (EDIT) EPS (Diluted) (2019 - 2025)

Analysis

Editas Medicine (EDIT) EPS (Diluted) (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 12.23
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 7.15
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.02 Bn 44.02 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.43 Bn 27.59 Bn - 0.15
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
10 Editas Medicine 284.24 Mn 137.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.28
Jun 30, 2025 -0.61
Mar 31, 2025 -0.91
Dec 31, 2024 -0.55
Sep 30, 2024 -0.75
Jun 30, 2024 -0.82
Mar 31, 2024 -0.76
Dec 31, 2023 -0.25
Sep 30, 2023 -0.55
Jun 30, 2023 -0.56
Mar 31, 2023 -0.69
Dec 31, 2022 -0.88
Sep 30, 2022 -0.81
Jun 30, 2022 -0.78
Mar 31, 2022 -0.73
Dec 31, 2021 -0.61
Sep 30, 2021 -0.57
Jun 30, 2021 -0.81
Mar 31, 2021 -0.86
Dec 31, 2020 -1.07